IN THIS ISSUE

Managing Editor's Memo
Frank Diamond
Legislation & Regulation
Others aren’t so sure. Public hearings demanded as a former executive alleges the insurer hasn’t acted like a not-for-profit.
Medication Management
Thomas Reinke

Jo-Ellen Abou Nader

Soaring prices and aggressive marketing fuel a buying frenzy for these specially made agents. The industry says it is meeting a need.

Biologics in Development
Katherine T. Adams
Tomorrow's Medicine
Thomas Morrow, MD
Studies of Holoclar—approved in Europe but not yet in the U.S.—show impressive results and give LSC patients new hope.
News & Commentary
Frank Diamond